These medications mimic the hormone GLP-1, which helps regulate appetite and blood sugar
More importantly, people who lose weight after taking the new weight loss drug semaglutide have reduced risk factors for heart disease and diabetes such as waist circumference, blood lipids, blood sugar, and blood pressure, and their overall quality of life has also been improved
176 GLP-1RAs and diseases As a rising star in recent years, GLP-1RAs are not only effective in metabolic diseases but also play a role in non-metabolic disorders, affecting multiple systems including the musculoskeletal, nervous, cardiovascular, and digestive systems, and can even have implications in oncological diseases
The number 157 refers to the specific 15-amino-acid fragment within that parent protein
Also, the data that is available points to possible complications for the fetus if someone takes semaglutide while pregnant